Reuters logo
4 months ago
BRIEF-Celyad: USPTO rejects new reexamination request against Celyad's US patent for production of allogeneic TCR-deficient CAR-T cells
March 16, 2017 / 8:40 AM / 4 months ago

BRIEF-Celyad: USPTO rejects new reexamination request against Celyad's US patent for production of allogeneic TCR-deficient CAR-T cells

1 Min Read

March 16 (Reuters) - Celyad Sa:

* The U.S. Patent and Trademark Office (USPTO) rejects new reexamination request against Celyad's US patent for production of allogeneic TCR-deficient CAR-T cells

* Patent remains valid and enforceable Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below